NEVRO CORP's ticker is and the CUSIP is 64157FAC7. A total of 16 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $39,609,000 | -31.4% | 42,000,000 | -31.1% | 0.79% | -33.8% |
| Q2 2022 | $57,724,000 | -11.7% | 61,000,000 | 0.0% | 1.19% | -18.5% |
| Q1 2022 | $65,368,000 | -4.1% | 61,000,000 | 0.0% | 1.46% | +2.2% |
| Q4 2021 | $68,194,000 | +95.5% | 61,000,000 | +134.6% | 1.43% | +110.0% |
| Q3 2021 | $34,876,000 | +67.2% | 26,000,000 | +116.7% | 0.68% | +83.6% |
| Q2 2021 | $20,863,000 | +14.6% | 12,000,000 | 0.0% | 0.37% | -3.1% |
| Q1 2021 | $18,208,000 | -16.9% | 12,000,000 | 0.0% | 0.38% | -11.5% |
| Q4 2020 | $21,915,000 | +16.7% | 12,000,000 | 0.0% | 0.43% | -5.3% |
| Q3 2020 | $18,784,000 | +14.3% | 12,000,000 | 0.0% | 0.46% | -4.6% |
| Q2 2020 | $16,438,000 | – | 12,000,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 109,251,000 | $102,018,584 | 3.22% |
| Opti Capital Management, LP | 19,500,000 | $18,574 | 1.34% |
| Context Capital Management, LLC | 10,702 | $10,207 | 0.82% |
| PFM Health Sciences, LP | 17,500,000 | $16,341,500 | 0.77% |
| LINDEN ADVISORS LP | 21,366,000 | $19,993,448 | 0.20% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,595,000 | $1,543,041 | 0.03% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,667,000 | $6,225,645 | 0.03% |
| Rock Springs Capital Management LP | 500,000 | $472,128 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 0 | $933 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |